Study Marks The Emergence Of Disease-Modifying Treatments For Autism Spectrum Disorders
Sunday, Jan. 30th 2011 6:24 AM
Researchers at Children’s Hospital Boston have begun a randomized, placebo-controlled trial to test a potential drug treatment for Rett syndrome, the leading known genetic cause of autism in girls. The drug, mecasermin, a synthetic form of insulin-like growth factor-1 (IGF-1), is already FDA-approved for children with short stature due to IGF-1 deficiency.
Related posts:
- Seaside Therapeutics Initiates Phase 2b Study Of STX209 In Autism Spectrum Disorders Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 2b study to evaluate the effects of STX209 (arbaclofen) on social impairment in children, adolescents and adults (ages 5 to 21) with autism spectrum disorders (ASD). The Company announced positive results from an open-label Phase 2a study of STX209 in September of […]...
- Dietary Issues In Children With Autism Spectrum Disorders Children with autism spectrum disorders (ASD) can demonstrate feeding problems, food refusal, and limited food preferences from infancy, but energy intake and growth are not affected…...
- Study Could Lead To New Treatments For Mood Disorders Study Could Lead To New Treatments For Mood Disorders...
- Study Aims To Uncover Source Of Sensory Problems In Autism The way the brain reacts differently to the sense of touch in people with Autism will be examined as part of an innovative Cardiff University study designed to create better understanding of the condition in Autism....
- Autism-Related Study Discovers How Drug Interferes With Neuronal Cell Function A York University study has shown for the first time how the drug misoprostol, which has been linked to neurodevelopmental defects associated with autism, interferes with neuronal cell function. It is an important finding because misoprostol is similar in structure to naturally-occurring prostaglandins, which are the key signaling molecules produced by fatty acids in the […]...
- Pitt Study Examines Environmental Risk Factors For Childhood Autism The University of Pittsburgh Graduate School of Public Health (GSPH) has launched a multi-year study to help identify environmental and other factors that may put children at risk for developing conditions within the autism spectrum disorders (ASDs)....
- The Autistic Mind: New Studies Show Spectrum Of Gene Variants Different people with autism can have very different symptoms. Health care providers think of autism as a “spectrum” disorder (ASD), a group of disorders with similar features. One person may have mild symptoms, while another may have serious symptoms. But they both have an autism spectrum disorder....
- Routine Autism Screening Not Necessary, Say Canadian Researchers Researchers from McMaster University believe that routine autism screening for all children is not necessary. They say that “there is not enough sound evidence supporting the implementation of a routine population-based screening program for autism.” Their report is published in the journal Pediatrics....
- Study Linking Autism To MMR Vaccine “An Elaborate Fraud” Study Linking Autism To MMR Vaccine "An Elaborate Fraud"...
- McMaster Researchers Say Routine Screening For Autism Not Needed Proposals recommending routine screening of all children for autism gets a thumbs down from researchers at McMaster University. In a study in the online edition of the journal Pediatrics, the researchers say there is “not enough sound evidence to support the implementation of a routine population-based screening program for autism....
- Research Provides Important Insight Into ‘Systemizing’ Theory Of Autism A new study from Cambridge University has for the first time found that autism diagnoses are more common in an IT-rich region. The Medical Research Council (MRC) funded study, published in the Journal of Autism and Developmental Disorders, has important implications for service provision in different regions and for the ‘hyper-systemizing’ theory of autism....
- Weaker Brain "Sync" May Be Early Sign Of Autism In a novel imaging study of sleeping toddlers, scientists at the University of California, San Diego Autism Center of Excellence report that a diminished ability of a young brain’s hemispheres to “sync” with one another could be a powerful, new biological marker of autism, one that might enable an autism diagnosis at a very young […]...
- Johns Hopkins Researchers Create New Mouse Model Of Autism In an effort to unravel the tangled biology of autism, Johns Hopkins scientists have created a mouse model that mimics a human mutation of a gene known to be associated with autism spectrum disorders. Experiments with the engineered mouse reveal a molecular mechanism by which mutations of the gene named Shank3 affect the brain and […]...
- Autism Detected In Unique Vocal Signature Of Baby Talk Using a new type of “vocal signature” technology that focuses on sound patterns rather than words in child vocalizations and baby talk, researchers in the US say they have proved in principle that it is possible to screen for autism spectrum disorders in young children; they also hope the new method will greatly enhance the […]...
Posted on Sunday, Jan. 30th 2011 6:24 AM | by Share of Cost | in Share of Cost | No Comments »